Balchem CORP 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
BCPC
Balchem CORPBalchem Corporation's 2024 10-K filing reveals a 3.4% increase in net sales and an 18.4% increase in net earnings compared to the previous year, driven by growth in the Human Nutrition and Health segment.
NASDAQ
BCPC
Balchem CORP10-K: Balchem Corporation Details Securities Registered Under the 1934 Exchange Act in Form 10-K Filing
Balchem Corporation's Form 10-K filing details the company's securities registered under Section 12 of the Securities Exchange Act of 1934, primarily its common stock.